» Articles » PMID: 24582666

Invoking the Power of Thrombospondins: Regulation of Thrombospondins Expression

Overview
Journal Matrix Biol
Publisher Elsevier
Date 2014 Mar 4
PMID 24582666
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing evidence suggests critical functions of thrombospondins (TSPs) in a variety of physiological and pathological processes. With the growing understanding of the importance of these matricellular proteins, the need to understand the mechanisms of regulation of their expression and potential approaches to modulate their levels is also increasing. The regulation of TSP expression is multi-leveled, cell- and tissue-specific, and very precise. However, the knowledge of mechanisms modulating the levels of TSPs is fragmented and incomplete. This review discusses the known mechanisms of regulation of TSP levels and the gaps in our knowledge that prevent us from developing strategies to modulate the expression of these physiologically important proteins.

Citing Articles

Activation-induced thrombospondin-4 works with thrombospondin-1 to build cytotoxic supramolecular attack particles.

Cassioli C, Capitani N, Staton C, Schirra C, Finetti F, Onnis A Proc Natl Acad Sci U S A. 2025; 122(6):e2413866122.

PMID: 39903110 PMC: 11831147. DOI: 10.1073/pnas.2413866122.


Thrombospondins: Conserved mediators and modulators of metazoan extracellular matrix.

Adams J Int J Exp Pathol. 2024; 105(5):136-169.

PMID: 39267379 PMC: 11574667. DOI: 10.1111/iep.12517.


Thrombospondin-1 Drives Cardiac Remodeling in Chronic Kidney Disease.

Julovi S, Trinh K, Robertson H, Xu C, Minhas N, Viswanathan S JACC Basic Transl Sci. 2024; 9(5):607-627.

PMID: 38984053 PMC: 11228122. DOI: 10.1016/j.jacbts.2024.01.010.


Thrombospondin-4 deletion does not exacerbate muscular dystrophy in β-sarcoglycan-deficient and laminin α2 chain-deficient mice.

Zaren P, Gawlik K Sci Rep. 2024; 14(1):14757.

PMID: 38926599 PMC: 11208443. DOI: 10.1038/s41598-024-65473-8.


Thbs1 regulates skeletal muscle mass in a TGFβ-Smad2/3-ATF4-dependent manner.

Vanhoutte D, Schips T, Minerath R, Huo J, Kavuri N, Prasad V Cell Rep. 2024; 43(5):114149.

PMID: 38678560 PMC: 11217783. DOI: 10.1016/j.celrep.2024.114149.


References
1.
Lopez-Dee Z, Pidcock K, Gutierrez L . Thrombospondin-1: multiple paths to inflammation. Mediators Inflamm. 2011; 2011:296069. PMC: 3134184. DOI: 10.1155/2011/296069. View

2.
Wu M, Tzeng C, Wu L, Huang K, Chou C . Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis. Cancer J. 2004; 10(1):27-32. DOI: 10.1097/00130404-200401000-00007. View

3.
Murphy-Ullrich J, Mosher D . Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation. J Cell Biol. 1987; 105(4):1603-11. PMC: 2114655. DOI: 10.1083/jcb.105.4.1603. View

4.
Stenvang J, Lindow M, Kauppinen S . Targeting of microRNAs for therapeutics. Biochem Soc Trans. 2008; 36(Pt 6):1197-200. DOI: 10.1042/BST0361197. View

5.
Stenvang J, Kauppinen S . MicroRNAs as targets for antisense-based therapeutics. Expert Opin Biol Ther. 2007; 8(1):59-81. DOI: 10.1517/14712598.8.1.59. View